Endonovo Therapeutics (OTCQB: ENDV) is a commercial stage developer of non-invasive medical devices designed to deliver its proprietary Electroceutical Therapy for the treatment of inflammatory conditions, cardiovascular diseases and central nervous system disorders. Endonovo's Electroceutical Thera... Endonovo Therapeutics (OTCQB: ENDV) is a commercial stage developer of non-invasive medical devices designed to deliver its proprietary Electroceutical Therapy for the treatment of inflammatory conditions, cardiovascular diseases and central nervous system disorders. Endonovo's Electroceutical Therapy is FDA-Cleared for the palliative treatment of pain and post-surgical edema (swelling) and CE Marked for the promotion of wound healing and the palliative treatment of pain and post-surgical edema. Endonovo's Electroceutical Therapy has CMS National Coverage for the treatment of chronic wounds. The Company's current pipeline of clinical-stage Electroceutical Therapies targets cardiovascular diseases and central nervous system disorders, including ischemic heart disease, acute concussions, post-concussion syndrome, traumatic brain injury (TBI) and multiple sclerosis. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 6.0E-5 | 6 | 0.001 | 0.00106 | 0.001 | 29164 | 0.00100413 | CS |
4 | 0.00011 | 11.5789473684 | 0.00095 | 0.0011 | 0.0009 | 134385 | 0.00097517 | CS |
12 | -4.0E-5 | -3.63636363636 | 0.0011 | 0.0016 | 0.0008 | 396509 | 0.00130222 | CS |
26 | -0.00044 | -29.3333333333 | 0.0015 | 0.002 | 0.0007 | 1804595 | 0.00105408 | CS |
52 | -0.008575 | -88.9984431759 | 0.009635 | 0.016 | 0.0007 | 1348998 | 0.00210585 | CS |
156 | -0.01754 | -94.3010752688 | 0.0186 | 0.028 | 0.0007 | 599326 | 0.00528559 | CS |
260 | -0.00474 | -81.724137931 | 0.0058 | 3.9 | 0.0007 | 617493 | 0.01982806 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관